Cargando…
Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway)
PURPOSE: We evaluated he effects of molecular guided-targeted therapy for intractable cancer. Also, the epidemiology of druggable gene alterations in Chinese population was investigated. MATERIALS AND METHODS: The Long March Pathway (ClinicalTrials.gov identifier: NCT03239015) is a non-randomized, o...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995917/ https://www.ncbi.nlm.nih.gov/pubmed/36910668 http://dx.doi.org/10.3389/fonc.2023.860711 |